Correction to FDA Accepts Innovent, Eli Lilly Application Article
19 May 2021 - 12:02AM
Dow Jones News
Innovent Biologics Inc. and Eli Lilly & Co. said the U.S.
Food and Drug Administration is currently planning to hold an
advisory committee meeting to discuss their biologics license
application for sintilimab injection. "FDA Accepts Innovent, Eli
Lilly Application for Sintilimab," published at 6:27 a.m. ET,
incorrectly reported in the second paragraph that the agency isn't
planning such a meeting.
(END) Dow Jones Newswires
May 18, 2021 09:47 ET (13:47 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Eli Lilly (NYSE:LLY)
Historical Stock Chart
From Feb 2024 to Mar 2024
Eli Lilly (NYSE:LLY)
Historical Stock Chart
From Mar 2023 to Mar 2024